WASHINGTON - The Food and Drug Administration silenced one of its drug experts who raised safety concerns weeks before Merck   Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes, the chairman of the Senate Finance Committee said Thursday...